GlycoNexGlycoNex
  • Home
  • About Us
  • Core Technology
  • Platform
  • Pipeline
  • Investors
    • Financials
    • Shareholder Services
    • Corporate Governance
    • Investor Conference
    • Share Transfer Agency and Spokesman
      • English (United States)
      • 中文(繁體．台灣)

Right from the beginning

NEWS

2024-12-24 GlycoNex Announces Licensing Agreement for SPD8 Biosimilar
2024-12-24 GlycoNex Announces Licensing Agreement for SPD8 Biosimilar
Read More
2024-12-17 GlycoNex Announces First Patient Dosed in Phase 3 Clinical Trial for Denosumab Biosimilar
Read More
2024-11-12 GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production
Read More
Tel
+ (886) 2-2697-4168
Fax
+ (886) 2-2697-1168
+ (886) 2-2697-5168
Email
mail@glyconex.com.tw
Join us
104徵才網站
Address
8F., No.97, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221, Taiwan
  • Home
  • About Us
  • Core Technology
  • Platform
  • Pipeline
  • Investors
    • Financials
    • Shareholder Services
    • Corporate Governance
    • Investor Conference
    • Share Transfer Agency and Spokesman
  • Search Icon
  • language
    • 中文
    • English